Biology Reference
In-Depth Information
52. Mansfield JR, Gossage KW, Hoyt CC, Levenson RM. Autofluorescence removal,
multiplexing, and automated analysis methods for in-vivo fluorescence imaging.
J Biomed Opt
2005;
10
:41207.
53. Davis SC, Dehghani H, Wang J, Jiang S, Pogue BW, Paulsen KD. Image-guided dif-
fuse optical fluorescence tomography implemented with Laplacian-type regularization.
Opt Express
2007;
15
:4066-82.
54. Sato A, Klaunberg B, Tolwani R. In vivo bioluminescence imaging.
Comp Med
2004;
54
:631-4.
55. Zrazhevskiy P, Sena M, Gao X. Designing multifunctional quantum dots for bio-
imaging, detection, and drug delivery.
Chem Soc Rev
2010;
39
:4326-54.
56. Ntziachristos V, Ripoll J, Wang LV, Weissleder R. Looking and listening to light: the
evolution of whole-body photonic imaging.
Nat Biotechnol
2005;
23
:313-20.
57. Blum G, Weimer RM, Edgington LE, Adams W, Bogyo M. Comparative assessment
of substrates and activity based probes as tools for non-invasive optical imaging of cys-
teine protease activity.
PLoS One
2009;
4
:e6374.
58. Signore A, Mather SJ, Piaggio G, Malviya G, Dierckx RA. Molecular imaging of in-
flammation/infection: nuclear medicine and optical imaging agents and methods.
Chem
Rev
2010;
:3112-45.
59. Turk B. Targeting proteases: successes, failures and future prospects.
Nat Rev Drug
Discov
2006;
5
:785-99.
60. Chudakov DM, Matz MV, Lukyanov S, Lukyanov KA. Fluorescent proteins and their
applications in imaging living cells and tissues.
Physiol Rev
2010;
90
:1103-63.
61. Welser K, Adsley R, Moore BM, Chan WC, Aylott JW. Protease sensing with nano-
particle based platforms.
Analyst
2011;
136
:29-41.
62. Gao W, Xing B, Tsien RY, Rao J. Novel fluorogenic substrates for imaging beta-
lactamase gene expression.
J Am Chem Soc
2003;
125
:11146-7.
63. Maeda H, Ishida N, Kawauchi H, Tsujimura K. Reaction of fluorescein-isothiocyanate
with proteins and amino acids. I. Covalent and non-covalent binding of fluorescein-
isothiocyanate and fluorescein to proteins.
J Biochem
1969;
65
:777-83.
64. French T, So PT, Weaver Jr. DJ, Coelho-Sampaio T, Gratton E, Voss Jr. EW, et al.
Two-photon fluorescence lifetime imaging microscopy of macrophage-mediated
antigen processing.
J Microsc
1997;
185
:339-53.
65. Horino K, Kindezelskii AL, Elner VM, Hughes BA, Petty HR. Tumor cell invasion of
model 3-dimensional matrices: demonstration of migratory pathways, collagen disrup-
tion, and intercellular cooperation.
FASEB J
2001;
15
:932-9.
66. Bogdanov AJ, Mazzanti M, Castillo G, Bolotin E. Protected graft copolymer (PGC) in
imaging and therapy: a platform for the delivery of covalently and non-covalently
67. Weissleder R, Tung CH, Mahmood U, Bogdanov Jr. A. In vivo imaging of tumors with
protease-activated near-infrared fluorescent probes.
Nat Biotechnol
1999;
17
:375-8.
68. Mahmood U, Tung CH, Bogdanov Jr. A, Weissleder R. Near-infrared optical imaging
of protease activity for tumor detection.
Radiology
1999;
213
:866-70.
69. Tung CH, Mahmood U, Bredow S, Weissleder R. In vivo imaging of proteolytic
enzyme activity using a novel molecular reporter.
Cancer Res
2000;
110
:4953-8.
70. Bremer C, Tung CH, Weissleder R. In vivo molecular target assessment of matrix
metalloproteinase inhibition.
Nat Med
2001;
60
:743-8.
71. Chen J, Tung CH, Mahmood U, Ntziachristos V, Gyurko R, Fishman MC, et al. In
vivo imaging of proteolytic activity in atherosclerosis.
Circulation
2002;
105
:2766-71.
72. Ntziachristos V, Tung CH, Bremer C, Weissleder R. Fluorescence molecular tomog-
raphy resolves protease activity in vivo.
Nat Med
2002;
8
:757-60.
73. Jaffer FA, Tung CH, Gerszten RE, Weissleder R. In vivo imaging of thrombin activity
in experimental thrombi with thrombin-sensitive near-infrared molecular probe.
Arterioscler Thromb Vasc Biol
2002;
22
:1929-35.
7
Search WWH ::
Custom Search